click tracking

About Us

Recent News

October, 2017: PEPVAX, INC. WINS “BEST IN SHOW” AT PHILADELPHIA 1ST PITCH LIFE SCIENCE COMPETITION
Read more...

August, 2017: PEPVAX BEGINS EFFICACY STUDY FOR LEAD CANDIDATE
Read more...

July, 2017: PepVax, Inc., an early stage biotechnology company developing an immunotherapy treatment for triple-negative breast cancer (TNBC), today announced several new milestones and upcoming events that demonstrate the company's continued growth...Read more...

Washington Business Journal: Can Indiegogo fund biotech? PepVax bets on it
Read more...